Related Experiment Videos
Filaricidal efficacy of anthelmintically active cyclodepsipeptides
H Zahner1, A Taubert, A Harder
1Institute for Parasitology, Justus Liebig University Giessen, Rudolf-Buchheim-Strasse 2, D-35392 Giessen, Germany. horst.zahner@vetmed.uni-giessen.de
International Journal for Parasitology
|October 12, 2001
Summary
The novel compound Bay 44-4400 effectively reduced microfilariae in filarial infections, unlike its parent compound PF 1022A. Bay 44-4400 demonstrated high efficacy across multiple administration routes and parasitic species.
Area of Science:
- Veterinary Parasitology
- Drug Discovery
- Tropical Medicine
Background:
- Filarial nematodes cause significant morbidity in humans and animals.
- Novel anthelmintic agents are needed to combat filarial infections.
- PF 1022A is a cyclodepsipeptide with known anthelmintic activity.
Purpose of the Study:
- To evaluate the filaricidal efficacy of PF 1022A and its derivative Bay 44-4400.
- To compare the efficacy of these compounds against different filarial species and life stages.
- To determine the minimum effective and curative doses for Bay 44-4400.
Main Methods:
- Infection of Mastomys coucha with Litomosoides sigmodontis, Acanthocheilonema viteae, and Brugia malayi.
- Administration of PF 1022A and Bay 44-4400 via oral, subcutaneous, and spot-on routes.
- Quantification of microfilaremia and assessment of adulticidal activity.
Main Results:
- PF 1022A showed limited efficacy, causing only temporary microfilaria reduction.
- Bay 44-4400 was highly effective against microfilariae of all tested species and routes.
- Bay 44-4400 demonstrated adulticidal effects against A. viteae and pathological alterations in intrauterine stages of L. sigmodontis and B. malayi.
Conclusions:
- Bay 44-4400 is a potent microfilaricide with broad-spectrum activity against filarial parasites.
- The compound's ability to alter intrauterine stages may contribute to long-lasting microfilaremia reduction.
- Bay 44-4400 shows promise as a therapeutic agent for filarial infections.